CGRP receptor antagonists
US7452903B2 · kind B2 · utility
16Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 2007 |
| Grant date | Nov 18, 2008 |
| Priority date | — |
| Expiry date | Mar 14, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds of Formula I:and Formula II:(where variables R1, R2, R3, R4, A, B, G, J, Q, T, U, V, W, X and Y are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.